Caterpillar Stock (NYSE: CAT): Price, Bobcat Lawsuits, Autonomous Truck Deal and 2025–2026 Forecast – December 8, 2025

Caterpillar Stock (NYSE: CAT): Price, Bobcat Lawsuits, Autonomous Truck Deal and 2025–2026 Forecast – December 8, 2025

Quick Take All figures and opinions below are as of the close on December 8, 2025 and are for information only, not personal investment advice. Caterpillar stock today: price, performance and valuation As of Monday, December 8, 2025, Caterpillar Inc. (NYSE: CAT) is changing hands at roughly $595–600 per share, down about 1% on the day but still hovering close to recent all‑time highs. Aggregated quote services show CAT around $595.5–599.5 intraday, depending on the feed. CoinCodex+2MarketBeat+2 The bigger story is the extraordinary run in 2025: On valuation: In short, Caterpillar is no longer a classic cyclical “value” stock. After
Legend Biotech (LEGN) Stock Hits 52‑Week Low After UBS Cut: December 8, 2025 News, Outlook and Forecast

Legend Biotech (LEGN) Stock Hits 52‑Week Low After UBS Cut: December 8, 2025 News, Outlook and Forecast

Legend Biotech Corp. (NASDAQ: LEGN) shares are under heavy pressure on December 8, 2025, trading in the mid‑$20s and touching a new 52‑week low around $25.66 during the session. The slide comes despite strong clinical momentum for its flagship CAR‑T therapy CARVYKTI® and robust revenue growth, as investors react to valuation resets and ongoing concerns about profitability and cash flow. Investing.com+1 This article rounds up the key news and analysis on Legend Biotech stock from December 8, 2025 and the days immediately preceding it, and looks at what Wall Street expects next for LEGN. Disclaimer: This article is for information
CrowdStrike (CRWD) Stock News Today: Q3 2026 Earnings Beat, AWS Awards and Wall Street Forecasts Into 2026

CrowdStrike (CRWD) Stock News Today: Q3 2026 Earnings Beat, AWS Awards and Wall Street Forecasts Into 2026

December 8, 2025 — Midday market update CrowdStrike Holdings, Inc. (NASDAQ: CRWD) is back in the spotlight today as one of the most-searched stocks on Zacks and a top “cybersecurity stock to watch” on MarketBeat, following a strong fiscal Q3 2026 earnings report, fresh AI-driven product launches, and new accolades from Amazon Web Services (AWS). Finviz Below is a detailed look at today’s share price, the latest earnings and guidance, new product and partnership news, and how Wall Street currently values and forecasts CrowdStrike stock. CrowdStrike Stock Price Today (December 8, 2025) As of around 12:40 p.m. Eastern on December
8 December 2025
Warby Parker (WRBY) Stock Soars on Google AI Glasses Timeline: Price Action, Earnings and 2026 Forecasts as of December 8, 2025

Warby Parker (WRBY) Stock Soars on Google AI Glasses Timeline: Price Action, Earnings and 2026 Forecasts as of December 8, 2025

Updated December 8, 2025 Warby Parker Inc. (NYSE: WRBY) is suddenly trading like an AI story, not just an eyewear retailer. Shares jumped around 15% on Monday, December 8, 2025, with the stock recently changing hands near $21.51, after fresh disclosures and media coverage confirmed that Google and Warby Parker plan to launch AI-powered smart glasses in 2026 as part of the Android XR platform.GuruFocus+1 The surge caps a dramatic rebound from autumn lows, coming just weeks after a mixed reaction to the company’s Q3 2025 earnings, where Warby Parker delivered strong growth and a return to profitability but narrowly
8 December 2025
Arrowhead Pharmaceuticals (ARWR) Soars to Fresh Highs on Alzheimer’s Trial and FDA Breakthrough Wins

Arrowhead Pharmaceuticals (ARWR) Soars to Fresh Highs on Alzheimer’s Trial and FDA Breakthrough Wins

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is finishing 2025 with the kind of momentum small-molecule biotechs daydream about. On 8 December 2025, the RNA interference (RNAi) specialist climbed to a new 52‑week high near $69 per share after the company announced it had dosed the first subjects in its Alzheimer’s disease trial ARO‑MAPT and highlighted a string of recent FDA victories and deal-driven cash inflows. Arrowhead Pharmaceuticals, Inc.+2MarketBeat+2 The rally caps a stunning year in which Arrowhead stock has delivered a year‑to‑date return of roughly 270% and a one‑year gain in the 160–200% range, depending on the data provider, vastly outpacing
8 December 2025
MercadoLibre (MELI) Stock Today: December 8, 2025 Update on Price, Q3 Results, Bond Deal and Analyst Forecasts

MercadoLibre (MELI) Stock Today: December 8, 2025 Update on Price, Q3 Results, Bond Deal and Analyst Forecasts

As of Monday, December 8, 2025, MercadoLibre, Inc. (NASDAQ: MELI) remains one of the most closely watched growth stocks in emerging markets. The Latin American e‑commerce and fintech leader is trading a little above $2,080 per share, giving it a market capitalization of roughly $105–108 billion, with a 52‑week range of $1,646 to $2,645 and a trailing P/E around 50–51. StockAnalysis+1 Yet despite strong fundamentals, the stock has fallen about 15–16% over the last six months, underperforming its e‑commerce peers as investors fret over margin pressure, intense competition and macro volatility in Latin America. Finviz At the same time, new
8 December 2025
Nurix Therapeutics (NRIX) Stock Soars on ASH 2025 Trial Data: Latest News, Analyst Forecasts and Outlook as of December 8, 2025

Nurix Therapeutics (NRIX) Stock Soars on ASH 2025 Trial Data: Latest News, Analyst Forecasts and Outlook as of December 8, 2025

Nurix Therapeutics, Inc. (NASDAQ: NRIX) is back in the spotlight. On December 8, 2025, the biotech stock surged roughly 20% intraday after the company released new Phase 1 data for its Bruton’s tyrosine kinase (BTK) degrader bexobrutideg (NX‑5948) in blood cancers at the American Society of Hematology (ASH) Annual Meeting and scheduled a corporate webcast for this evening. MarketBeat+3GlobeNewswire+3GlobeNewswire+3 The rally comes barely two months after Nurix posted a weak third quarter and executed a large equity raise, underscoring how heavily sentiment in this name is tied to the clinical trajectory of its degrader pipeline. ChartMill+2StockAnalysis+2 NRIX stock today: price
Carvana (CVNA) Soars on S&P 500 Inclusion: Latest News, Stock Forecast and Analysis as of December 8, 2025

Carvana (CVNA) Soars on S&P 500 Inclusion: Latest News, Stock Forecast and Analysis as of December 8, 2025

Carvana Co. (NYSE: CVNA) is back in the spotlight. On Monday, December 8, 2025, the online used-car retailer’s shares surged again after S&P Dow Jones Indices confirmed that Carvana will join the benchmark S&P 500 index on December 22, 2025. The stock traded around $454 in late session, up roughly 14% on the day and near record highs, capping a year in which the stock has gained well over 100% and staged one of the most dramatic recoveries in recent market history. Reuters According to Reuters, Carvana’s market value has swelled to roughly $87 billion, now exceeding both Ford and
8 December 2025
Kymera Therapeutics (KYMR) Stock Soars on KT‑621 Eczema Data: What December 8, 2025 Means for Investors

Kymera Therapeutics (KYMR) Stock Soars on KT‑621 Eczema Data: What December 8, 2025 Means for Investors

Kymera Therapeutics, Inc. (NASDAQ: KYMR) delivered one of the biggest biotech moves on Wall Street today. On Monday, December 8, 2025, Kymera stock surged more than 40% intraday, trading around $96 late in the session after touching an intraday high above $100, on volume far above normal. MarketBeat The catalyst: very strong Phase 1b data for KT‑621, a once‑daily oral STAT6 degrader for atopic dermatitis (eczema) and broader Type 2 inflammatory diseases. GlobeNewswire Below is a full breakdown of today’s news, analyst reactions, and what the move could mean for Kymera stock in the months ahead. Kymera Therapeutics Stock Rockets
Wave Life Sciences (WVE) Stock Explodes on Obesity Drug Breakthrough – What the New Data and Wall Street Forecasts Signal

Wave Life Sciences (WVE) Stock Explodes on Obesity Drug Breakthrough – What the New Data and Wall Street Forecasts Signal

Published: December 8, 2025 WVE stock more than doubles on massive volume Wave Life Sciences Ltd. (NASDAQ: WVE) staged a spectacular rally on Monday after unveiling positive interim data from its Phase 1 INLIGHT trial for obesity drug candidate WVE‑007. Shares surged from a close of $7.49 on Friday, December 5 to intraday levels around $17–18, a gain in the range of 120%–140% and a new multi‑year high. Yahoo Finance+2Investing.com+2 Trading volume blew out to more than 100 million shares, roughly 40 times the stock’s recent average daily volume of about 2.5 million, underscoring intense speculative interest and likely short
8 December 2025
Confluent (CFLT) Soars on IBM’s $11 Billion Takeover: Deal Terms, Stock Outlook and Analyst Forecasts After December 8, 2025 Rally

Confluent (CFLT) Soars on IBM’s $11 Billion Takeover: Deal Terms, Stock Outlook and Analyst Forecasts After December 8, 2025 Rally

Confluent, Inc. (NASDAQ: CFLT) has suddenly shifted from a high-growth data‑infrastructure story to a classic M&A arbitrage play. On December 8, 2025, IBM and Confluent announced a definitive agreement under which IBM will acquire all outstanding Confluent shares for $31 in cash, valuing the data‑streaming specialist at around $11 billion enterprise value.IBM Newsroom+2ABC News+2 The news sent CFLT stock up roughly 29% in today’s session, as traders rapidly repriced the shares toward the proposed cash buyout price.MarketBeat Confluent Stock News Today: IBM Confirms $11 Billion Cash Deal IBM and Confluent jointly announced that they have entered into a definitive merger
Banco Bradesco (BBD) Stock on December 8, 2025: Is the Post‑Earnings Sell‑Off a Buying Opportunity?

Banco Bradesco (BBD) Stock on December 8, 2025: Is the Post‑Earnings Sell‑Off a Buying Opportunity?

Published: December 8, 2025 – Informational article, not investment advice. Key points Banco Bradesco stock today: price action and context Banco Bradesco S.A., Brazil’s second‑largest private bank and a diversified financial and insurance group, is back under the market microscope. Its NYSE‑listed ADRs trade around $3.35 on December 8, 2025, up slightly on the day and sitting close to the upper half of their 52‑week range between $1.84 and $3.77. Investing The calm today follows a stormy Friday: Despite this pullback, BBD has had a powerful 2025: In other words, the recent fall is happening after a major run‑up, not
8 December 2025
Boeing (BA) Stock Today: Spirit AeroSystems Deal Closes as Wall Street Sees Double‑Digit Upside

Boeing (BA) Stock Today: Spirit AeroSystems Deal Closes as Wall Street Sees Double‑Digit Upside

Published: December 8, 2025 – All data as of this date. This article is for informational purposes only and is not investment advice. Boeing (BA) Stock Snapshot on December 8, 2025 Boeing shares are trading around $206 per share on December 8, 2025, up roughly 2% on the day as investors react to a major supply‑chain acquisition and a more optimistic multi‑year outlook. StockAnalysis That price puts Boeing’s market value in the mid‑$150 billion range, with the stock sitting in the upper half of its 52‑week range of about $129–$243. StockAnalysis The main drivers behind today’s move and the recent
Vertiv Stock (VRT) on December 8, 2025: AI Data‑Center Darling Faces High Expectations After New Deals, Upgrades and a Dividend Hike

Vertiv Stock (VRT) on December 8, 2025: AI Data‑Center Darling Faces High Expectations After New Deals, Upgrades and a Dividend Hike

Published: December 8, 2025 Vertiv Holdings Co (often labeled Vertiv Holdings LLC on quote services, ticker NYSE: VRT) goes into the second week of December as one of Wall Street’s most closely watched AI‑infrastructure names. A powerful multi‑year rally, booming demand for AI data centers, a fresh $1 billion acquisition and multiple analyst upgrades have pushed the stock near record territory—while also raising the bar for future execution. TradingView+2Wikipedia+2 This article pulls together the latest news, forecasts and analysis as of December 8, 2025, to give a comprehensive snapshot of where Vertiv stands today. Vertiv stock price today and recent performance
Rigetti Computing (RGTI) Stock: December 8, 2025 News, Analyst Forecasts and Quantum Computing Outlook

Rigetti Computing (RGTI) Stock: December 8, 2025 News, Analyst Forecasts and Quantum Computing Outlook

As of market close on December 8, 2025, Rigetti Computing, Inc. (NASDAQ: RGTI) trades around $27.84 per share, down roughly 1% on the day, for a market capitalization of about $9.3 billion. The stock has swung between $3.31 and $58.15 over the past year and remains up several hundred percent year‑on‑year despite a violent November correction. Stocktwits+1 This article rounds up the latest news, forecasts and analysis available as of December 8, 2025, to help investors understand what’s really driving Rigetti’s hyper‑volatile quantum computing stock. 1. Rigetti Stock Today: Price, Volatility and Context A Nasdaq‑syndicated analysis notes that Rigetti is
Wimbledon Station Incident Today: Man Dies as Emergency on Line Triggers Major Rail Chaos Between London and Surrey

Wimbledon Station Incident Today: Man Dies as Emergency on Line Triggers Major Rail Chaos Between London and Surrey

London, Monday 8 December 2025 – A man has died after a major emergency incident near Wimbledon station that has shut key rail lines between London and Surrey, leaving thousands of commuters stranded and causing disruption expected to last all day, according to National Rail and train operators. National Rail+1 What Happened at Wimbledon Station? The incident was first reported near the railway in the Wimbledon area at around 2.27pm on Monday 8 December 2025, with National Rail logging the event at 14:27 and confirming that emergency services were on scene. National Rail+1 Local and national media report that emergency
8 December 2025
Spirit AeroSystems (SPR) Stock on December 8, 2025: Boeing Takeover, NYSE Delisting and What Shareholders Get

Spirit AeroSystems (SPR) Stock on December 8, 2025: Boeing Takeover, NYSE Delisting and What Shareholders Get

Spirit AeroSystems Holdings, Inc. (NYSE: SPR) has effectively reached the end of its life as a standalone public stock. On December 8, 2025, Boeing officially completed its acquisition of Spirit AeroSystems, halted trading in SPR, and kicked off the process to delist the shares from the New York Stock Exchange (NYSE).Boeing Investors+1 For anyone who owns SPR, tracks aerospace stocks, or just likes untangling big industrial deals, this is a pivotal day. Key takeaways for Spirit AeroSystems (SPR) on December 8, 2025 Let’s unpack what actually happened today, what it means for SPR stockholders, and how this reshapes the Boeing–Airbus–Spirit
Reddit (RDDT) Stock Today – December 8, 2025: AI Data Goldmine, r/popular Shake‑Up and What Analysts Expect Next

Reddit (RDDT) Stock Today – December 8, 2025: AI Data Goldmine, r/popular Shake‑Up and What Analysts Expect Next

Reddit, Inc. (NYSE: RDDT) is closing out 2025 with the kind of momentum most newly public tech companies can only dream of. The stock has almost doubled in the past six months, analysts are racing to lift price targets, and Wall Street is suddenly treating Reddit’s 20 years of user‑generated chatter as prime training fuel for artificial intelligence. Finviz+1 At the same time, management is ripping out one of the site’s most iconic features — the r/popular feed — and insiders are cashing in shares after a blowout earnings year. That cocktail of rapid growth, product upheaval, AI upside and
UK Stock Market Today: FTSE 100 Dips as Unilever Slumps on Magnum Spin‑Off (London Close, 8 December 2025)

UK Stock Market Today: FTSE 100 Dips as Unilever Slumps on Magnum Spin‑Off (London Close, 8 December 2025)

The UK stock market started the new week on the back foot on Monday, 8 December 2025, as investors juggled a landmark Unilever spin‑off, a renewed bond sell‑off and looming interest‑rate decisions from both the US Federal Reserve and the Bank of England. By the closing bell in London, the FTSE 100 had slipped around 0.2% to 9,645.09, while the FTSE 250 fell 0.7% to 21,921.28 and the AIM All‑Share lost 0.4% to 748.52. Alternative benchmarks told a similar story, with the Cboe UK 100 down 0.2%, the Cboe UK 250 off 0.6% and Cboe Small Companies down 0.9%. London South East Across the continent, the
DAX Today After the Bell: German Stock Market Edges Higher as Bayer and Kloeckner Rally – December 8, 2025

DAX Today After the Bell: German Stock Market Edges Higher as Bayer and Kloeckner Rally – December 8, 2025

Germany’s stock market started the new week on a cautious but broadly positive note. The DAX 40 finished Monday’s session just above the 24,000‑point mark, with modest gains driven by pharmaceuticals and defence stocks, even as real estate and consumer names weighed on the broader European market. Investing.com UK+1 Investors digested a stronger‑than‑expected German industrial production report, ongoing worries about the country’s weak growth outlook, and fresh takeover speculation in the steel sector – all under the shadow of this week’s pivotal U.S. Federal Reserve meeting. Market Close Snapshot: DAX Holds Above 24,000 At the close in Frankfurt on Monday, 8
8 December 2025

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop